While artificial tears are easily available over the counter remedies for DES, the use of artificial tears also has side effects that need to be kept in mind. Also, with some patients who require the use of artificial tears several times a day, regular artificial tears are not a good option. Technological advances associated with several years of research and development has addressed this issue with preservative free artificial tears.?Artificial Tears Market
The Artificial Tears market can be segmented on the basis of type as
polyethylene glycol and propylene glycol based tears
Oil-based emulsion tears
In terms of end-user age group, the Artificial Tears market has been segmented across the following:
Above 60 years of age
While the growth potential in regions such as Europe and North America still exist, the opportunities in developing economies in South America and APAC are poised to grow at higher rates comparatively. In Europe, an increasing ageing population is one aspect that will enhance the growth of the market. Changing lifestyles resulting in an increasing number of DES patients coupled with the increasing spending power of the population in these regions is expected to drive the growth of the artificial tear market in South America and Asia Pacific.
The market has been segmented based on the following geographies:
Following are just a few of the companies that are operating in the Artificial Tears market:
Abott Medical Optics Inc
Johnson & Johnson
Bausch and Lomb
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Artificial Tears– Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Artificial Tears– Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Artificial Tears Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Artificial Tears Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Artificial Tears Market– By Type:
6.1. Cellulose-derived tears
6.2. Glycerin-derived tears
6.3. Polyethylene glycol and propylene glycol based tears
6.4. Oil-based emulsion tears
7. Artificial Tears Market– By End-user Age Group:
7.1. 20-40 years
7.2. 40-60 years
7.3. Above 60 years
8. Artificial Tears Market– By Geography:
8.2. Global Study
8.3.1. North America
9. Artificial Tears Market– Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
10.1. Bausch and Lomb
10.2. Abott Medical Optics, Inc.
10.3. Johnson and Johnson
10.4. Novartis International AG
10.5. Allergan, Inc.
10.6. Akorn, Inc.
10.7. Santen Pharmaceuticals
10.8. Novagali Pharma S.A.
10.10. Alcon, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights